A randomized single ascending dose (SAD)/ multiple ascending dose study to evaluate BMS-986036 in Obese healthy adults.
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2017
At a glance
- Drugs BMS 986036 (Primary)
- Indications Fibrosis; Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 30 Jan 2017 New trial record